SVB Wealth’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,345
| Closed | -$109K | – | 1642 |
|
2025
Q1 | $109K | Buy |
+1,345
| New | +$109K | ﹤0.01% | 391 |
|
2022
Q2 | – | Sell |
-60
| Closed | -$5K | – | 862 |
|
2022
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 784 |
|
2021
Q4 | $6K | Sell |
60
-3,709
| -98% | -$371K | ﹤0.01% | 794 |
|
2021
Q3 | $473K | Sell |
3,769
-24
| -0.6% | -$3.01K | 0.01% | 617 |
|
2021
Q2 | $514K | Sell |
3,793
-2,041
| -35% | -$277K | 0.01% | 565 |
|
2021
Q1 | $791K | Buy |
5,834
+486
| +9% | +$65.9K | 0.01% | 402 |
|
2020
Q4 | $752K | Buy |
5,348
+1,489
| +39% | +$209K | 0.01% | 381 |
|
2020
Q3 | $430K | Buy |
3,859
+100
| +3% | +$11.1K | 0.01% | 445 |
|
2020
Q2 | $420K | Buy |
3,759
+3,699
| +6,165% | +$413K | 0.01% | 395 |
|
2020
Q1 | $4K | Hold |
60
| – | – | ﹤0.01% | 567 |
|
2019
Q4 | $6K | Buy |
+60
| New | +$6K | ﹤0.01% | 639 |
|